STOP-stroke: STroke Outcome Prediction in the Acute Treatment Setting

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Zurich

About this trial

The STOP-stroke project aims at improving prediction of outcome early after stroke. In order to achieve this, we need to understand reasons (important variables) for prediction in a real clinical prognostication process.

We aim to:

1. Test the predictive performance of stroke neurologists for outcome prediction (NIHSS at 24 hours and 3 months and mRS at 3 months after stroke onset) prospectively and in a real clinical setting, and to explore the most important baseline variables in their prognostication process. 2. Test the prediction performance of our DL models when being provided with structured clinical and/or imaging information from the same patients as the neurologists; and to discover most relevant features of the input data. 3. Use the information gained from our experiments for improving our DL algorithm. This will include an error analysis on the missclassifications of models and neurologists to understand the pitfalls of both approaches. We anticipate to develop a robust, reliable and clinically feasible application ready for testing in a prospective, observational trial.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients from up to 18 years years of age without any upper age limit.

Patients with clinical suspicion of acute ischemic stroke (acute onset focal neurological deficit) at the discretion of the paramedic or treating physician within 24 hours of symptom onset including wake-up situation and unclear symptom onset planned for clinically indicated neuroimaging.

Patients with externally performed neuroimaging before admission or referral to the USZ will be included from the time point N2 on if no refusal of use of data is documented.

Disqualifiers

None

Trial population

Patients with suspicion of acute ischemic stroke independent of stroke etiology, who received medical imaging (CT or MRI scan of the brain depending on the clinical indication) after admission to hospital at USZ or before at an external hospital sending the patient to the USZ for treatment.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

actual stroke related disability

actual stroke related disability assessed by the mRS at 3 months as well as the NIHSS (stroke severity) after 24 hours and 3 months after acute ischemic stroke (AIS)

Time frame
assessed 90 days after stroke onset

Secondary outcomes

1

predicted stroke related disability

predicted mRS scores of the treating neurologists on the stroke unit one side and the predicted mRS by the DL model on the other

Time frame
90 days after stroke onset

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.